Christos Kotanidis, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adipose Tissue | 9 | 2023 | 3312 | 0.750 |
Why?
|
Arteritis | 1 | 2019 | 159 | 0.560 |
Why?
|
Acute Coronary Syndrome | 2 | 2025 | 2184 | 0.470 |
Why?
|
Coronary Angiography | 5 | 2025 | 4493 | 0.440 |
Why?
|
Coronary Artery Disease | 6 | 2024 | 6544 | 0.410 |
Why?
|
Medicine | 1 | 2020 | 942 | 0.400 |
Why?
|
Radiation Injuries | 1 | 2019 | 1181 | 0.390 |
Why?
|
Cardiovascular System | 1 | 2019 | 841 | 0.380 |
Why?
|
Myocardial Ischemia | 1 | 2022 | 2128 | 0.370 |
Why?
|
Myocarditis | 1 | 2018 | 802 | 0.340 |
Why?
|
Heart | 1 | 2022 | 4414 | 0.310 |
Why?
|
Plaque, Atherosclerotic | 4 | 2020 | 1529 | 0.240 |
Why?
|
Lymphocele | 1 | 2022 | 19 | 0.200 |
Why?
|
Adipokines | 2 | 2021 | 308 | 0.190 |
Why?
|
Endometrial Neoplasms | 2 | 2022 | 1378 | 0.190 |
Why?
|
State Medicine | 1 | 2022 | 219 | 0.180 |
Why?
|
Myocardial Revascularization | 1 | 2024 | 793 | 0.170 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 15652 | 0.170 |
Why?
|
Coronary Vessels | 3 | 2020 | 3096 | 0.170 |
Why?
|
Ceramides | 1 | 2021 | 201 | 0.170 |
Why?
|
Arteries | 2 | 2021 | 1118 | 0.160 |
Why?
|
Tomography | 1 | 2021 | 443 | 0.160 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2025 | 10383 | 0.160 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2019 | 246 | 0.150 |
Why?
|
ABO Blood-Group System | 1 | 2020 | 380 | 0.140 |
Why?
|
Osteoprotegerin | 1 | 2018 | 178 | 0.140 |
Why?
|
Carcinoma, Endometrioid | 1 | 2020 | 272 | 0.140 |
Why?
|
Awards and Prizes | 1 | 2021 | 364 | 0.140 |
Why?
|
Angiography | 1 | 2022 | 1581 | 0.140 |
Why?
|
Research Personnel | 1 | 2021 | 590 | 0.130 |
Why?
|
Endopeptidases | 1 | 2019 | 759 | 0.130 |
Why?
|
Interleukin-1 | 1 | 2019 | 1243 | 0.120 |
Why?
|
Syndrome | 1 | 2022 | 3271 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 4 | 2023 | 20659 | 0.120 |
Why?
|
Face | 1 | 2020 | 1028 | 0.120 |
Why?
|
Blood Vessels | 1 | 2019 | 1113 | 0.110 |
Why?
|
Ischemia | 1 | 2022 | 1909 | 0.100 |
Why?
|
Inflammation | 3 | 2024 | 10850 | 0.100 |
Why?
|
Oxidation-Reduction | 3 | 2023 | 2218 | 0.090 |
Why?
|
Acute Disease | 2 | 2021 | 7232 | 0.090 |
Why?
|
Humans | 22 | 2025 | 765968 | 0.090 |
Why?
|
Predictive Value of Tests | 4 | 2023 | 15398 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36532 | 0.090 |
Why?
|
Cardiology | 1 | 2021 | 1702 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2020 | 5302 | 0.080 |
Why?
|
Societies, Medical | 1 | 2021 | 3956 | 0.080 |
Why?
|
Health Status | 1 | 2021 | 4080 | 0.080 |
Why?
|
Atherosclerosis | 2 | 2021 | 3424 | 0.070 |
Why?
|
Obesity | 2 | 2021 | 13076 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2659 | 0.070 |
Why?
|
Cytokines | 1 | 2022 | 7421 | 0.070 |
Why?
|
MicroRNAs | 1 | 2023 | 3785 | 0.070 |
Why?
|
Mental Health | 1 | 2021 | 3278 | 0.070 |
Why?
|
Risk Assessment | 6 | 2025 | 24282 | 0.060 |
Why?
|
Aged | 8 | 2025 | 171117 | 0.060 |
Why?
|
Insulin Resistance | 1 | 2018 | 3985 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5189 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12807 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9525 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20124 | 0.050 |
Why?
|
Prospective Studies | 3 | 2022 | 54802 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12976 | 0.050 |
Why?
|
Female | 10 | 2025 | 396112 | 0.040 |
Why?
|
Rh-Hr Blood-Group System | 1 | 2020 | 64 | 0.040 |
Why?
|
Superoxides | 1 | 2021 | 383 | 0.040 |
Why?
|
Obesity, Abdominal | 1 | 2023 | 369 | 0.040 |
Why?
|
Myocardium | 2 | 2023 | 4760 | 0.040 |
Why?
|
Sphingolipids | 1 | 2021 | 178 | 0.040 |
Why?
|
Oxidants | 1 | 2019 | 166 | 0.040 |
Why?
|
Pericardium | 1 | 2023 | 679 | 0.040 |
Why?
|
Germany | 1 | 2020 | 882 | 0.040 |
Why?
|
Parity | 1 | 2020 | 931 | 0.030 |
Why?
|
Hysterectomy | 1 | 2022 | 864 | 0.030 |
Why?
|
Prognosis | 3 | 2024 | 29922 | 0.030 |
Why?
|
Signal Transduction | 1 | 2019 | 23601 | 0.030 |
Why?
|
Risk Factors | 4 | 2025 | 74840 | 0.030 |
Why?
|
Lymph Node Excision | 1 | 2022 | 1259 | 0.030 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2019 | 702 | 0.030 |
Why?
|
Middle Aged | 7 | 2025 | 223009 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39193 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2022 | 2887 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2019 | 3586 | 0.030 |
Why?
|
Genetic Markers | 1 | 2019 | 2601 | 0.030 |
Why?
|
Health Status Disparities | 1 | 2025 | 1880 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3624 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2019 | 1499 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 1668 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2021 | 22223 | 0.030 |
Why?
|
Ligands | 1 | 2019 | 3273 | 0.030 |
Why?
|
Menopause | 1 | 2020 | 1659 | 0.020 |
Why?
|
Metabolomics | 1 | 2021 | 1668 | 0.020 |
Why?
|
Adipocytes | 1 | 2018 | 1194 | 0.020 |
Why?
|
Vascular Diseases | 1 | 2019 | 1159 | 0.020 |
Why?
|
Sex Factors | 1 | 2025 | 10603 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2023 | 9550 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2022 | 3454 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2019 | 1884 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3141 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6832 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2025 | 3413 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2021 | 4427 | 0.020 |
Why?
|
Adiposity | 1 | 2019 | 1890 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2900 | 0.020 |
Why?
|
Male | 6 | 2024 | 363698 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14751 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8501 | 0.020 |
Why?
|
Cell Movement | 1 | 2019 | 5194 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2022 | 11206 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10563 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10070 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3236 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4034 | 0.010 |
Why?
|
Animals | 3 | 2023 | 168764 | 0.010 |
Why?
|
Cognition | 1 | 2021 | 7049 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12509 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2024 | 11499 | 0.010 |
Why?
|
Time Factors | 1 | 2025 | 40065 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11641 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 13039 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10808 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16721 | 0.010 |
Why?
|
Adult | 3 | 2021 | 223044 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15880 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22332 | 0.010 |
Why?
|
Adolescent | 2 | 2018 | 88835 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 14071 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2025 | 65188 | 0.010 |
Why?
|
Mice | 1 | 2023 | 81819 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42500 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 59489 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 59889 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 81514 | 0.010 |
Why?
|
Child | 1 | 2018 | 80564 | 0.010 |
Why?
|